Israeli Prime Minister Naftali Bennett received a third shot of Pfizer-BioNtech’s COVID-19 vaccine, after Israel extended its booster campaign for people over 40 in an attempt to slow the spread of the Delta variant
COVID-19 vaccine on Friday, after Israel extended its booster campaign for people over 40 to try to curb the Delta coronavirus variant.
The Health Ministry said on Friday boosters would now be administered to people over 40 whose second shot was at least five months ago. It recommended teachers, health workers, carers of the elderly, and pregnant women of all ages have the shot. Israeli health officials have said they are seeing initial signs that the booster campaign may be slowing the rate at which cases are climbing.About 1 million eligible Israelis have not taken any dose of the vaccine and severe cases have been climbing, though few fully vaccinated 40 to 50-year-olds have fallen seriously ill.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Israeli doctors find severe COVID-19 breakthrough cases mostly in older, sicker patientsIn Israel's COVID-19 wards, doctors are learning which vaccinated patients are most vulnerable to severe illness, amid growing concerns about instances in which the shots provide less protection against the worst forms of the disease.
Read more »
Welcome! You are invited to join a meeting: Conversaciones Comunitarias de COVID-19 y la Vacuna de COVID-19 | Community Conversations about COVID-19 and the COVID-19 Vaccine. After registering, you will receive a confirmation email about joining the meeting.
Read more »
VidCon 2021 Canceled Due to COVID-19 Concerns, Rescheduled for Next SummerThe Anaheim event, which brings together online creators and fans, was supposed to take place in person from Oct. 22 to 24.
Read more »
Three Food-Industry Trends Influenced by COVID-19While COVID-19 is not the first pandemic traced back to eating animals, it is the first to coincide with the rise of alternative proteins.
Read more »
AstraZeneca's antibody therapy prevents COVID-19, study showsCORRECTION: AstraZeneca said that its antibody therapy met the main goal of preventing COVID-19 in a late-stage study, putting the British drugmaker on track to potentially offer an alternative to vaccines We will delete an earlier tweet without a video
Read more »
England's COVID-19 prevalence drops to 1 in 80, ONS saysThe prevalence of COVID-19 infections in England was around 1 in 80 people in the week ending Aug. 14, Britain's Office for National Statistics (ONS) said on Friday, slightly lower than the previous week's estimate of 1 in 75.
Read more »